{"meta":{"query_hash":"b6d3f038977f","filters":{"venue":"HIV Therapy"},"cohort_total":4,"direct_labels_cover":0,"predictions_cover":4,"exported":4,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/b6d3f038977f","api":"https://metacan.xera.ac/api/v1/cohort?venue=HIV+Therapy"},"results":[{"id":"W2039892394","doi":"10.2217/hiv.10.43","title":"HIV Treatment in the Criminal Justice System","year":2010,"lang":"en","type":"article","venue":"HIV Therapy","topic":"HIV, Drug Use, Sexual Risk","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AIDS Vancouver","funders":"","keywords":"Criminal justice; Human immunodeficiency virus (HIV); Criminology; Economic Justice; Medicine; Political science; Psychology; Virology; Law","score_opus":0.06647687383109963,"score_gpt":0.35770652865936126,"score_spread":0.29122965482826163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039892394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9747271,0.00026420984,0.000052662286,0.0021943257,0.00035130902,0.00061986357,0.000012075679,0.000088601155,0.021689862],"genre_scores_gemma":[0.9947545,0.0001444939,0.00039612953,0.0008803536,0.0006511047,0.00010328917,0.000022422619,0.00002986558,0.003017842],"study_design_codex":"qualitative","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989292,0.00010082681,0.00020974145,0.00022867977,0.00026182158,0.0002697448],"domain_scores_gemma":[0.9990611,0.0001749583,0.00005032488,0.0005879347,0.00003866671,0.00008701178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002895252,0.00017631393,0.00024323672,0.000079123056,0.00008157919,0.000024305664,0.00017587264,0.00008880331,0.0001428271],"category_scores_gemma":[0.00002795002,0.0000982881,0.00006650018,0.0001488063,0.000057782658,0.000040267983,0.000008188503,0.00027559392,0.00057810475],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00397896,0.005505669,0.038529526,0.0011064336,0.00042454596,0.0024977361,0.45638016,0.000034597564,0.15294233,0.025158877,0.031915948,0.28152522],"study_design_scores_gemma":[0.022768583,0.0034520144,0.09113452,0.00031743755,0.0016094891,0.0015957666,0.38845852,0.0024137706,0.015972832,0.000115348965,0.4712768,0.00088491396],"about_ca_topic_score_codex":0.00009346623,"about_ca_topic_score_gemma":0.00007474587,"teacher_disagreement_score":0.43936086,"about_ca_system_score_codex":0.00008600327,"about_ca_system_score_gemma":0.00008440424,"threshold_uncertainty_score":0.743056},"labels":[],"label_agreement":null},{"id":"W2105950729","doi":"10.2217/17584310.3.2.109","title":"Stavudine in First-Line Antiretroviral Regimens in Resource-Limited Settings: Time for a Better Solution","year":2009,"lang":"en","type":"article","venue":"HIV Therapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Abbott Laboratories","keywords":"Stavudine; Antiretroviral therapy; Resource (disambiguation); Human immunodeficiency virus (HIV); First line; Medicine; Intensive care medicine; Computer science; Virology; Viral load; Internal medicine","score_opus":0.015903672131937892,"score_gpt":0.260794820296549,"score_spread":0.2448911481646111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105950729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93469983,0.00038385767,0.00013348766,0.06292267,0.00002284321,0.0010119249,0.000013316068,0.00008093055,0.0007311281],"genre_scores_gemma":[0.96755093,0.00023450327,0.005096133,0.0055429926,0.00021433343,0.0000922721,0.00059386966,0.00004285864,0.020632107],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987757,0.000036286725,0.00033166626,0.00030291313,0.00017165851,0.00038173885],"domain_scores_gemma":[0.9995563,0.000065893364,0.00007220142,0.00021081092,0.000031660533,0.00006312234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027694923,0.00019813114,0.0003473312,0.0003071645,0.000054850007,0.000013017793,0.000062036794,0.00009957619,0.000091355614],"category_scores_gemma":[0.000028653922,0.00016365666,0.00008202153,0.0003277625,0.000024625542,0.000066453606,0.000008919366,0.00013232692,0.000063053136],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0115543185,0.00493597,0.40647402,0.00012705756,0.00037169154,0.0005629563,0.012318121,0.00007151867,0.03770962,0.00015934232,0.32301188,0.2027035],"study_design_scores_gemma":[0.06064593,0.004444165,0.27760175,0.0010881107,0.000087973225,0.00004826001,0.00020675312,0.007937866,0.013291125,0.0008234635,0.6328471,0.0009775115],"about_ca_topic_score_codex":0.000005905318,"about_ca_topic_score_gemma":0.000012468966,"teacher_disagreement_score":0.3098352,"about_ca_system_score_codex":0.00018727983,"about_ca_system_score_gemma":0.000038645932,"threshold_uncertainty_score":0.6673725},"labels":[],"label_agreement":null},{"id":"W2152830821","doi":"10.2217/hiv.09.40","title":"The K65R Mutation in HIV-1 Reverse Transcriptase: Genetic Barriers, Resistance Profile and Clinical Implications","year":2009,"lang":"en","type":"article","venue":"HIV Therapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research","keywords":"Resistance mutation; Stavudine; Lamivudine; Virology; Nevirapine; Biology; Zidovudine; Emtricitabine; Didanosine; Abacavir; Reverse transcriptase; Drug resistance; Genetics; Viral load; Human immunodeficiency virus (HIV); Virus; RNA; Viral disease; Antiretroviral therapy; Hepatitis B virus","score_opus":0.01831863474859166,"score_gpt":0.3086983567991576,"score_spread":0.29037972205056595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152830821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79381466,0.008562198,0.00046288955,0.19177575,0.00011042551,0.0019881565,0.00005065893,0.00009156783,0.003143656],"genre_scores_gemma":[0.95069814,0.010016517,0.008258742,0.0021297778,0.00010633156,0.00015103306,0.00013042844,0.00002173176,0.02848733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991326,0.0000809401,0.0002965808,0.00021725493,0.00010697688,0.00016565187],"domain_scores_gemma":[0.99949884,0.000076748525,0.00004930929,0.00023507472,0.000034496465,0.00010553274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022948184,0.000105467465,0.00015576993,0.00004212045,0.00014589616,0.0000193609,0.00005617638,0.000054001906,0.000054746084],"category_scores_gemma":[0.000032173648,0.000071093185,0.000050254712,0.00015348273,0.000071789014,0.000040686242,0.0000026539924,0.00010862424,0.000033869354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025381546,0.00080983073,0.43168098,0.000030779967,0.00029418067,0.00018504396,0.005203013,0.0000021050876,0.0030834998,0.004805105,0.2783999,0.27296737],"study_design_scores_gemma":[0.0038595377,0.00012349349,0.76967776,0.00004838248,0.000034699056,0.000014487905,0.00017999005,0.000038698865,0.0002795813,0.0012663626,0.22436626,0.00011071995],"about_ca_topic_score_codex":0.0000016015447,"about_ca_topic_score_gemma":0.0000269347,"teacher_disagreement_score":0.33799678,"about_ca_system_score_codex":0.00004464878,"about_ca_system_score_gemma":0.000100308585,"threshold_uncertainty_score":0.2899096},"labels":[],"label_agreement":null},{"id":"W2162585640","doi":"10.2217/hiv.09.54","title":"At the Forefront of Retrovirology Research: Frontiers of Retrovirology","year":2009,"lang":"en","type":"article","venue":"HIV Therapy","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Palette (painting); Mosaic; Virology; Political science; Computer science; Medicine; Geography","score_opus":0.023918437658571698,"score_gpt":0.34301248678411284,"score_spread":0.3190940491255411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162585640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840197,0.01013856,0.0035289004,0.0008744515,0.00012619754,0.00016417317,0.000013252657,0.000005087544,0.0011296667],"genre_scores_gemma":[0.99600905,0.0021182757,0.00041047626,0.00021850891,0.000107550906,0.0000067205324,0.000026188645,0.000012119111,0.001091126],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990816,0.000112601636,0.00020205721,0.00020703339,0.00013908386,0.00025764134],"domain_scores_gemma":[0.9993143,0.00002171938,0.0000636102,0.00049162965,0.00007195431,0.00003677665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004136696,0.00009832225,0.00017396187,0.000056471727,0.00005310696,0.0000023449402,0.00026488095,0.00014886432,0.000032461932],"category_scores_gemma":[0.000043483185,0.00007121541,0.00009384072,0.00008674233,0.00024349654,0.0000012099539,0.000054095788,0.00011712598,0.0000028014188],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042397305,0.000037738584,0.0029529308,0.000003176869,0.00004249449,8.0523665e-7,0.0001329927,0.00024602844,0.96542424,0.00013717769,0.025329018,0.005269407],"study_design_scores_gemma":[0.0007676038,0.0018907367,0.021331657,0.0000028115905,0.0000062618915,0.000008309373,0.00008731329,0.00008793441,0.8749444,0.000498818,0.10027903,0.00009515535],"about_ca_topic_score_codex":0.000010097012,"about_ca_topic_score_gemma":0.000014844909,"teacher_disagreement_score":0.090479895,"about_ca_system_score_codex":0.000011470606,"about_ca_system_score_gemma":0.000026627842,"threshold_uncertainty_score":0.290408},"labels":[],"label_agreement":null}]}